HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)
Conditions
Prostate Cancer Metastatic Disease · Oligometastatic Prostate Cancer (OMPC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ICO, Saint-Herblain, France
Study leads
Loïg Vaugier, MD
Principal Investigator
ICO